- Benchmark ASINB0GLGBHR24
- MarketplaceUS
- Category ID10728331
- Analyzed Products
- Keywordhome health
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥49.22estimated
- Data Date2026-08-10
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不值得进入。 目前只有1个新品牌、2个新上架样本，表面成功率50%，但样本极小，不能当作健康机会；更重要的是，跑通的只有 HOMENURSE 的差异化款 B0GLGBHR24，普通款 B0H5JZTFVD 直接失活，说明这里不是“上新就能卖”的市场，而是必须靠明确功能升级才能换来销量。
证据上，市场没有出现你要求的30~100+新品牌涌入的超饱和信号，但已经很明显地进入了“同质化淘汰”阶段。 B0GLGBHR24 售价 82.04 美元，毛利率 28.5%，月销 700、月营收 57,428 美元，最近月利润约 16,366.98 美元，启动成本约 59,490.70 美元；它赢在“窄体可调宽、能过小门框和小空间”的功能差异。相反，B0H5JZTFVD 只是基础窄折叠助行器加滑雪脚垫，没有明显差异化，直接没有活跃销量。新品牌成功率按当前样本是 50%，但只有 2 个新产品，样本太小；目前也没有看到200-300+评论的明显刷评型对手。市场趋势上，2026年4月出现唯一成功款，2026年6月出现失败款，说明后进产品并没有变得更容易赚钱，反而是在被快速筛掉。
对两类玩家的判断：大品牌可以考虑，但前提是有产品创新和足够首投；小品牌不建议进。 你现在的 500,000 CNY 预算可以覆盖 B0GLGBHR24 这种级别的单品启动，但这只够“开局”，不包含长期研发、品牌和认证成本；如果你没有类似的功能升级能力，普通款会很难打。可跟的对象是 HOMENURSE 和 ASIN B0GLGBHR24；不该跟的是基础款 B0H5JZTFVD。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing结论：用户预算 500,000 CNY 可以入场，但这个市场不值得进。 现在看到的是明显的高门槛+低容错市场：新品牌里已出现 50% 成功、50% 失败，但样本几乎只有 HOMENURSE 一个新品牌，说明信号太弱；真正有说服力的是，卖得好的 B0GLGBHR24 需要靠明确功能差异化和持续活跃销售，而 B0H5JZTFVD 这种基础款直接失活，说明同质化产品很容易死掉。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):50.00%Which new brands have these successful new listings?Alternatives- 药店/医疗用品店的基础款标准助行器：通常更便宜、现场可试走，适合只需要基础支撑、不一定要窄幅可调的用户。
- 二手标准助行器（本地二手平台/社区转让）：价格明显更低，适合短期康复、预算有限或不确定是否长期使用的人。
- 租赁助行器（医疗器械租赁/康复设备租借）：按周或按月付费，初始成本更低，适合术后恢复期或临时行动辅助需求。
- 四脚拐/腋拐：比带轮助行器更轻便、购买门槛更低，适合需要少量支撑但不想买大件设备的用户。
- 家用滚轮椅或轻便轮椅的短期替代方案：如果主要是在室内/短距离移动，通常比专门的窄幅助行器更容易获得和使用，且不需要学习复杂的步态配合。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场可以进，但只适合大品牌；对小品牌不友好，且不建议硬冲。原因很直接：当前样本里只有1个新品牌、2个新上架，盈利率只有50%，还没出现你要求的那种30~100+新品牌涌入的超饱和信号，但已经能看出成败分化很大，真正能跑通的不是“普通助行器”，而是窄体可调宽、解决狭窄空间通行痛点的差异化产品。
证据上，HOMENURSE 的成功款 B0GLGBHR24 是明确可抄的样本：售价 $82.04，毛利率 28.5%，月销 700，月营收 $57,428，最近月利润 $16,366.98，评价 105、评分 4.3，启动投入约 $59,490.70，其中广告约 $13,379.46。它赢在基于旧款做功能升级，不是重新发明品类：窄体、可调宽、能进小门框和小空间，目标人群非常清楚；相反，失败款 B0H5JZTFVD 只是基础窄折叠助行器加滑雪脚垫，没有明显差异化，直接卖不动。这里没有看到“200~300评论/12个月”的明显刷评型竞争对手，但成功款 105 评就已经做出高销量，说明这类市场靠的还是产品力与投放效率，不是纯评论堆量。
结论很明确：大品牌可以进，前提是有能力做功能创新和较高首投；小品牌不应进入这个通用款赛道，除非能做出像 B0GLGBHR24 这种强功能差异化，而且单个 ASIN 预算至少要按约 $59k 级别去准备，用户500,000 CNY预算是够的，但只是够“启动”，不够长期烧品牌和研发。 大品牌该跟的对象是 HOMENURSE 和 ASIN B0GLGBHR24；小品牌要么学它的“窄体+可调宽+室内通行优化”，要么就别做，普通款 B0H5JZTFVD 这种不要碰。
New products with Highest revenueLeast investment in new productsMost investment in new productsHOMENURSE
Recent Monthly Revenue (USD):$57,428.00(700pcs/month)B0GLGBHR24 (4.3/5 (105 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0GLGBHR24 (4.3/5 (105 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0H5JZTFVDBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场目前不适合进入：样本里只有2个可判断产品，利润分布各占50%，但真正赚钱的新品牌只有1个，且完全没有出现30%以上的稳定利润带，说明这不是可复制的高机会市场。 更关键的是，唯一的成功新品牌 HOMENURSE 走的是“基于老款改良 + 功能差异化”的路线，卖到 82.04 美元、月销 700 件、月营收 57,428 美元、净利率 28.5%，而失败款 B0H5JZTFVD 同品牌新上架却直接不赚钱，说明这里不是靠简单上新就能赢，必须有明确功能创新和较强执行力。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0GLGBHR24HOMENURSE2026-04-12Yes$82.04700pcs$57428.028.5%$16366.98Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0GLGBHR24HOMENURSE2026-04-12Yes$82.04700pcs$57428.028.5%$16366.98#New Product Success Rates
Listing这个市场不适合进入，原因很直接：当前样本里只有1个新品牌 HOMENURSE，利润结果是1胜1负，表面上看不算崩，但真正拉开差距的是新产品里只有 B0GLGBHR24 这一个可验证成功案例，且它靠的是基于旧款改良+功能差异化，而不是低门槛复制；另一款 B0H5JZTFVD 直接失败，说明这个类目对“基础款”容忍度很低。更关键的是，市场里已出现明显的价格与差异化压力，不是适合小品牌轻松切入的地方。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
HOMENURSENonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
HOMENURSE#Success Rate by Entry Time
Listing这个市场现在不值得进入，结论是偏向不通过。 目前能看到的新品牌只有 HOMENURSE，近两款新发布一胜一负，表面上是 50% 成功率，但样本太小，不能当成健康市场信号；更关键的是，市场没有显示出明确的扩张红利，反而是靠单一品牌、单一爆款在撑场。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 0 2026 0 0 0 0 1 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 1 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 1 2026/7 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesHOMENURSEB0GLGBHR24 (4.3/5 (105 Reviews))HOMENURSE Narrow Walkers for Seniors, Folding Walker for Small Space 350lbs
This listing is deemed profitablePrice (USD)$82.04Released TypeNew Release (2026-04-12)Brand is a new entry in this marketSize and Weight43.4 x 34.3 x 13.1 cm, 3084.00gProfitable Factors
Based on old ASINDistinct functions and featuresDesign & Appearance
窄体可调宽结构，能通过狭窄门框和小空间Key Buying Motive
可通过更换轮子内外侧实现宽度调节，兼顾窄通道通过性与日常行走稳定性Target Customers
专门面向家中走道狭窄、卫生间空间有限、需要室内通行更顺畅的老人和康复用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$57,428.00700 sold in the past 30 days · as of 2026年8月Net Profit Margin
Sea Freight23.76% / 28.50%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight4.40% / 9.13%Peak / Non PeakSales & BSR Performance